Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting.

Autor: Chehade M; Mount Sinai Center for Eosinophilic Disorders, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: mirna.chehade@mssm.edu., Wright BL; Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, Ariz; Section of Allergy and Immunology, Division of Pulmonology, Phoenix Children's Hospital, Phoenix, Ariz., Atkins D; Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo., Aceves SS; Rady Children's Hospital, San Diego, Calif; Division of Allergy, Immunology, University of California-San Diego, San Diego, Calif., Ackerman SJ; Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, Ill., Assa'ad AH; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio., Bauer M; Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo., Collins MH; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio., Commins SP; Division of Allergy & Immunology, Center for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC., Davis CM; Division of Immunology, Allergy, and Retrovirology, Baylor College of Medicine, Houston, Tex; Texas Children's Hospital Food Allergy Program, Texas Children's Hospital, Houston, Tex., Dellon ES; Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC., Doerfler B; Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Chicago, Ill., Gleich GJ; Department of Dermatology, School of Medicine, University of Utah School of Medicine, Salt Lake City, Utah., Gupta SK; Children's of Alabama, University of Alabama at Birmingham, Birmingham, Ala., Hill DA; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pa; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa., Jensen ET; Wake Forest University School of Medicine, Winston-Salem, NC., Katzka D; Division of Digestive and Liver Diseases, Columbia University Irving Medical Center, New York, NY., Kliewer K; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio., Kodroff E; Campaign Urging Research for Eosinophilic Disease, Lincolnshire, Ill., Kottyan LC; Cincinnati Children's Research Foundation, Division of Human Genetics, Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Kyle S; Campaign Urging Research for Eosinophilic Disease, Lincolnshire, Ill., Muir AB; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pa; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa., Pesek RD; Division of Allergy/Immunology, University of Arkansas for Medicine Sciences, Little Rock, Ark; Arkansas Children's Hospital, Little Rock, Ark., Peterson K; Division of Gastroenterology, University of Utah Health, Salt Lake City, Utah., Shreffler WG; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Massachusetts General Hospital, Boston, Mass; Food Allergy Center, Massachusetts General Hospital, Boston, Mass., Spergel JM; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pa; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa., Strobel MJ; American Partnership for Eosinophilic Disorders, Atlanta, Ga., Wechsler J; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill., Zimmermann N; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio., Furuta GT; Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo., Rothenberg ME; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio.
Jazyk: angličtina
Zdroj: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Dec; Vol. 152 (6), pp. 1382-1393. Date of Electronic Publication: 2023 Sep 03.
DOI: 10.1016/j.jaci.2023.08.021
Abstrakt: The Consortium of Eosinophilic Gastrointestinal Diseases and The International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the 2022 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured a review of recent discoveries in the basic biology and pathogenesis of eosinophilic gastrointestinal diseases (EGIDs) in addition to advances in our understanding of the clinical features of EGIDs. Diagnostic and management approaches were reviewed and debated, and clinical trials of emerging therapies were highlighted. Herein, we briefly summarize the breakthrough discoveries in EGIDs.
(Copyright © 2023 American Academy of Allergy, Asthma & Immunology. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: